| BUG-V (aka: BIPMF) BIOPHAGE PHARMA INC JUL 07 2006  06:13 AM Signs an MOU with Two U.S. Companies
 
 Indus & ISC to develop & manufacture a new generation of PDS(R)
 biosensors
 
 Biophage Pharma Inc. ("Biophage") announces that it has signed a
 memorandum of understanding with two U.S. companies, Indus Instruments,
 Houston, Texas ("Indus"), and International Science Consulting, LLC, West
 Haven, Connecticut, ("ISC"), for the development and manufacturing of the a
 new generation of PDS(R) biosensors.
 
 Under this MOU, Indus and ISC will develop for Biophage proprietary
 equipment for the detection of live bacterial pathogens and their toxins.
 As compensation, Indus and ISC will receive US$50,000 and 3,800,000
 non-transferable warrants, each such warrant entitling the holder thereof
 to purchase one common share of the capital of Biophage at any time, for a
 period of two years after the date of its grant. Out of the 3,800,000
 abovementioned warrants, 2,800,000 will be exercisable at a price of
 CAN$0.12 and 1,000,000 will be exercisable at a price of CAN$0.30. The
 parties have agreed to enter into a more detailed development agreement.
 "Over the coming weeks and months, I look forward to sharing with our
 stockholders the new technologies and commercial markets we will be
 entering with our new generation of biosensor technologies," commented Dr
 Mandeville, President and CEO of Biophage Pharma Inc.
 "We are very excited with the opportunity to partner with Biophage
 Pharma and help them acquire in an opportune time, a competitive PDS(R)
 Biosensor units that will be reasonably priced and will offer a higher
 level of performance over conventional testing standards," stated Dr
 Sridhar Madala, President of Indus Instruments.
 
 About Biophage Pharma Inc.
 
 Biophage Pharma is a high potential Canadian biotechnology company
 focused on the development of novel phage-based technologies for the
 detection and management of live pathogens and cell cytotoxicity testing.
 Founded in 1995, Biophage Pharma has completed the development of its first
 prototype PDS (R) Biosensor and is entering in the pre-commercialization
 stage. The Corporation has also an important profit center that provides
 services in Immunogenicity and Immunotoxicity, in Beryllium sensitivity
 testing and MELISA (R) for the detection of allergy to more than 20
 different metals and a very large number of allergens including antibiotics
 (penicillin, Gentamycin) and pollens. (www.biophagepharma.com;
 www.immunotoxlabs.com).
 
 About Indus Instruments
 
 Indus Instruments is a Texas based company specialized in the design,
 development, and manufacture of electronic devices and computer systems for
 the medical, industrial, and scientific instrumentation markets. Since 1992
 Indus has helped numerous clients in a wide variety of fields turn their
 ideas into products. Indus offers services ranging from design reviews, R&D
 proposal assistance, prototype development, patent applications to
 manufacturing assistance. (www.indusintruments.com).
 
 About International Science Consulting, LLC
 
 International Science Consulting, LLC is a Connecticut based scientific
 and general management consulting firm whose mission is to help early stage
 companies create and sustain a competitive advantage. ISC uses its
 knowledge and resource capabilities to assist products, systems and
 technologies development. ISC provides focused, practical and high
 value-added scientific, management and business development services to
 individuals and corporations.
 
 The TSX Venture Exchange does not accept responsibility for the
 adequacy or accuracy of this release.
 
 Capitalization Report for Biophage Pharma Inc
 Shares Issued: 32221312
 Shares Escrow: 7090832
 
 TSX Venture closing price for Biophage Pharma I
 Date: 2006/07/06
 Closing Price: 0.110
 
 TEL:  (514) 496-1488    Biophage Pharma Inc.
 Rosemonde Mandeville M.B. Ch.B. PhD
 President and Chief Executive Officer
 EMAIL: rosemonde.mandeville@biophagepharma.com
 
 TEL:  (514) 939-3989    Renmark Financial Communications Inc.
 Investor Relations: Christine Stewart
 EMAIL: cstewart@renmarkfinancial.com
 Christina Lalli
 EMAIL: clalli@renmarkfinancial.com
 INET : www.renmarkfinancial.com
 
 TEL:  (281) 286-1130    Indus Instruments: Sridhar Madala PhD
 President
 EMAIL: Sridhar@indusinstruments.com
 
 .
 |